Complete Hydatidiform Mole

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Complete Hydatidiform Mole trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT02892877

The French National Reference Centre of GTD

The French Gestational Trophoblastic Disease (GTD) centre has been set up and active by registering, monitoring and treating women with GTD since november 1999.…

France25,500 participantsStarted 1999-11

All recent trials (4 shown)

Active — Not RecruitingNot Applicable

NCT01008501

Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles

The researchers' laboratory is studying a rare class of highly recurrent hydatidiform moles. These are usually complete hydatidiform moles (CHM), but sometimes…

United States100 participantsStarted 2000-11-07

UnknownPhase 2/3

NCT05203562

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

Prophylactic use of aromatase inhibitor is effective in decreasing the incidence of Gestational Trophoblastic Neoplasia (GTN) in patients with complete hydatidi…

Egypt200 participantsStarted 2020-06-01

Treatment: Suction evacuation, Letrozole tablets

Complete Hydatidiform Mole

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

The French National Reference Centre of GTD

All recent trials (4 shown)

Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

The French National Reference Centre of GTD

All recent trials (4 shown)

Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors